Press Release: INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - EW
SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), have until this upcoming Friday, December 13, 2024 to seek appointment as lead…
Press Release: INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - EW - Newscast
Sun, 23 Mar 2025 05:44:00 GMT CLICK HERE TO LEARN MORE ABOUT THIS LAWSUIT. Investors who purchased or acquired MONOLITHIC POWER securities during the Class Period may, no later than APRIL 7, 2025, seek to be appointed as a ...
Sun, 09 Mar 2025 00:35:00 GMT New York, New York--(Newsfile Corp. - March 9, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...
Mon, 12 Apr 2021 10:48:00 GMT reminds investors of the deadline for investors to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the ...
